Abstract
The goal of primary cytoreductive surgery for the treatment of advanced ovarian cancer (FIGO stages II–IV) should be to achieve a reduction to microscopic disease, as cytoreduction to nodules of less than 1 cm in maximum diameter is associated with a clear benefit in terms of overall survival compared with patients who have larger residual disease. 1 Shih KK Chi DS Maximal cytoreductive effort in epithelial ovarian cancer surgery. J Gynecol Oncol. 2010; 21: 75-80 Crossref PubMed Scopus (100) Google Scholar
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
